05:21 PM EST, 11/20/2024 (MT Newswires) -- Acadia Pharmaceuticals ( ACAD ) said in a late Wednesday filing that Chief Operating Officer Brendan Teehan will be involuntarily terminated without cause, effective immediately.

Chief Executive Catherine Adams will assume responsibilities of the COO role until a successor is appointed, the company said.

Teehan will remain with the company as a non-executive employee until Dec. 31, the company added.